Uvax Bio LLC
- Biotech or pharma, therapeutic R&D
Uvax Bio is a clinical stage, protein nanoparticle vaccine company focused on developing vaccines to address unmet clinical needs in the prevention of infectious diseases. Uvax Bio holds the exclusive worldwide rights to the 1c-SApNP® protein vaccine platform.